In oncology, PET imaging studies can provide valuable information on drug access to tumour tissue, which can be affected by a number of factors such as the P-glycoprotein (PgP) and breast cancer resistance protein (BCRP) [4, 5] drug efflux mechanisms and aberrant tumour vasculature [6] (Table 1). The gene discussed is ABCG2; the disease is neoplasm.